The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy

SL Cheong, S Federico, G Spalluto, KN Klotz… - Drug Discovery …, 2019 - Elsevier
Highlights•Parkinson's disease (PD) is a neurodegenerative disorder with complex
pathophysiological pathways.•The one-drug–single-target approach is inadequate in …

In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease

A Lemos, R Melo, AJ Preto, JG Almeida… - Current …, 2018 - ingentaconnect.com
Parkinson's Disease (PD) is a long-term neurodegenerative brain disorder that mainly
affects the motor system. The causes are still unknown, and even though currently there is …

Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach

L Zell, C Lainer, J Kollár, V Temml, D Schuster - Molecules, 2022 - mdpi.com
Diseases of the central nervous system are an alarming global problem showing an
increasing prevalence. Dopamine receptor D2 (D2R) has been shown to be involved in …

Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonyl-phenoxy) ethyl](propyl) amine (IRL790), a novel dopamine transmission modulator for the treatment of …

S Waters, C Sonesson, P Svensson, J Tedroff… - … of Pharmacology and …, 2020 - ASPET
IRL790 ([2-(3-fluoro-5-methanesulfonylphenoxy) ethyl](propyl) amine, mesdopetam) is a
novel compound in development for the clinical management of motor and psychiatric …

Synthesis toward Bivalent Ligands for the Dopamine D2 and Metabotropic Glutamate 5 Receptors

M Qian, E Wouters, JAR Dalton… - Journal of Medicinal …, 2018 - ACS Publications
In this study, we designed and synthesized heterobivalent ligands targeting heteromers
consisting of the metabotropic glutamate 5 receptor (mGluR5) and the dopamine D2 …

Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions

RE Salmas, M Yurtsever, M Stein, S Durdagi - Molecular diversity, 2015 - Springer
Homology model structures of the dopamine D2 receptor (D2R) were generated starting
from the active and inactive states of\upbeta β 2-adrenergic crystal structure templates. To …

Reversible photocontrol of dopaminergic transmission in wild-type animals

C Matera, P Calvé, V Casadó-Anguera… - International journal of …, 2022 - mdpi.com
Understanding the dopaminergic system is a priority in neurobiology and
neuropharmacology. Dopamine receptors are involved in the modulation of fundamental …

Synthesis and Characterization of a Novel Series of Agonist Compounds as Potential Radiopharmaceuticals for Imaging Dopamine D2/3 Receptors in Their High …

JP van Wieringen, V Shalgunov… - Journal of Medicinal …, 2014 - ACS Publications
Imaging of dopamine D2/3 receptors (D2/3R) can shed light on the nature of several
neuropsychiatric disorders in which dysregulation of D2/3R signaling is involved. Agonist …

Investigation of D1 Receptor–Agonist Interactions and D1/D2 Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling

M Malo, L Brive, K Luthman, P Svensson - ChemMedChem, 2012 - Wiley Online Library
The aim of this study was to use a combined structure and pharmacophore modeling
approach to extract information regarding dopamine D1 receptor agonism and D1/D2 …

Synthesis, pharmacological evaluation and QSAR modeling of mono-substituted 4-phenylpiperidines and 4-phenylpiperazines

F Pettersson, P Svensson, S Waters, N Waters… - European Journal of …, 2013 - Elsevier
A series of mono-substituted 4-phenylpiperidines and-piperazines have been synthesized
and their effects on the dopaminergic system tested in vivo. The structure activity relationship …